Search
for
Sort by
Research 61–90 of 762
- Alopecia areata-like and psoriasis after dupilumab use for atopic dermatitis
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
- Tralokinumab as a therapeutic option for patients with concurrent atopic dermatitis and alopecia areata
- Allergen desensitization reduces the severity of relapsed alopecia areata in dust‐mite allergic patients
- Udenafil Induces the Hair Growth Effect of Adipose-Derived Stem Cells
- Toll-like Receptor 3 Agonist, Polyinosinic-polycytidylic Acid, Upregulates Carbonic Anhydrase II in Human Keratinocytes
- Dupilumab Alters Both the Bacterial and Fungal Skin Microbiomes of Patients with Atopic Dermatitis
- Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- <i>Pinus thunbergii</i> bark extract rich in flavonoids promotes hair growth in dorsal skin by regulating inflammatory cytokines and increasing growth factors in mice
- Combined therapy with adipose tissue-derived mesenchymal stromal cells and meglumine antimoniate controls lesion development and parasite load in murine cutaneous leishmaniasis caused by Leishmania amazonensis
- RETRACTED: Interleukin‐33 links asthma to alopecia areata: Mendelian randomization and mediation analysis
- Effects of a complex mixture prepared from agrimonia, houttuynia, licorice, peony, and phellodendron on human skin cells
- Dupilumab in the treatment of severe atopic dermatitis refractory to systemic immunosuppression: case report
- Possible Immunomodulating Effect of Retinol on Cytokines Secretion in Patients with Recurrent Furunculosis
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Human Placenta Extract (HPH) Suppresses Inflammatory Responses in TNF-α/IFN-γ-Stimulated HaCaT Cells and a DNCB Atopic Dermatitis (AD)-Like Mouse Model
- 735 - A case series of dupilumab for vitiligo and alopecia areata in the setting of AD
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Alopecia areata in atopic dermatitis: coincidence or regularity?
- Advanced glycation end-products inhibit mesenchymal-epidermal interaction by up-regulating proinflammatory cytokines in hair follicles
- T Cells Promote Distinct Transcriptional Programs of Cutaneous Inflammatory Disease in Keratinocytes and Dermal Fibroblasts
- A Case of Unexpected Successful Treatment of Alopecia Areata With Tralokinumab in a Patient With Atopic Dermatitis
- Dupilumab for a 5‐year‐old child with prurigo nodularis
- Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions against Th2 Cytokine-Mediated Signaling
- 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins
- Current and future pharmacotherapy for alopecia areata
- Netherton syndrome: effect on ichthyosis linearis circumflexa with dupilumab
- Interleukins gene polymorphism in alopecia areata patients: a systematic review